RC
BSX icon

RegentAtlantic Capital’s Boston Scientific BSX Stock Holding History

RegentAtlantic Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.16M Sell
29,939
-3,832
-11% -$154K 0.03% 283
2022
Q2 		$1.26M Buy
33,771
+283
+0.8% +$11.5K 0.04% 269
2022
Q1 		$1.48M Sell
33,488
-6,545
-16% -$284K 0.04% 261
2021
Q4 		$1.7M Buy
40,033
+7,847
+24% +$330K 0.05% 242
2021
Q3 		$1.4M Buy
32,186
+43
+0.1% +$1.9K 0.04% 253
2021
Q2 		$1.37M Buy
32,143
+4,630
+17% +$195K 0.04% 251
2021
Q1 		$1.06M Buy
27,513
+2,419
+10% +$91.6K 0.04% 269
2020
Q4 		$902K Buy
25,094
+3,175
+14% +$114K 0.04% 254
2020
Q3 		$838K Buy
21,919
+5,158
+31% +$199K 0.04% 256
2020
Q2 		$588K Buy
16,761
+7,690
+85% +$277K 0.03% 280
2020
Q1 		$296K Buy
+9,071
New +$354K 0.02% 333
2015
Q1 		– Sell
-445
Closed -$5.9K – 432
2014
Q4 		$5.9K Buy
+445
New +$5.69K ﹤0.01% 990

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

RegentAtlantic Capital's BSX Position: Q3 2022 in Review

RegentAtlantic Capital reduced its Boston Scientific (BSX) stake by 11% in Q3 2022, selling an estimated $154K and leaving 29,939 shares worth $1.16M. The position accounts for 0.03% of the portfolio, ranked #283.

RegentAtlantic Capital first reported a position in BSX in Q4 2014 and has held it in 12 quarters since. The position peaked at $1.7M in Q4 2021. 864 funds tracked by Wall St. Rank hold BSX as of Q3 2022.

  • RegentAtlantic Capital held 29,939 shares of Boston Scientific worth $1.16M as of Q3 2022.
  • RegentAtlantic Capital sold 3,832 Boston Scientific shares in Q3 2022, an estimated $154K.
  • Boston Scientific made up 0.03% of RegentAtlantic Capital's portfolio in Q3 2022, its #283 holding.
  • RegentAtlantic Capital first reported a position in Boston Scientific in Q4 2014 and has held it in 12 quarters since.
  • RegentAtlantic Capital's Boston Scientific position peaked at $1.7M in Q4 2021.
  • 864 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.